BASAL CELL CARCINOMA METASTATIC

This adverse event was reported 17 times

These drugs are most commonly taken by patients reporting BASAL CELL CARCINOMA METASTATIC:

# Drug Count
0 VISMODEGIB 4
1 DENOSUMAB 3
2 BUROSUMAB 2
3 CEMIPLIMAB-RWLC 2
4 CYCLOSPORINE 2
5 ETANERCEPT 2
6 ACITRETIN 1
7 ADALIMUMAB 1
8 ADALIMUMAB-ATTO 1
9 AMLODIPINE 1
See all common drugs associated with BASAL CELL CARCINOMA METASTATIC

BASAL CELL CARCINOMA METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CEMIPLIMAB-RWLC 2 0.0010
1 ADALIMUMAB-ATTO 1 0.0006
2 VISMODEGIB 4 0.0004
3 NICOTINAMIDE 1 0.0004
4 BUROSUMAB 2 0.0003
5 ACITRETIN 1 0.0002
6 PHENYTOIN 1 0.0000
7 RIBOCICLIB 1 0.0000
8 LETROZOLE TABLETS 1 0.0000
9 CYCLOSPORINE 2 0.0000
See all drugs enriched for association with BASAL CELL CARCINOMA METASTATIC